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PATHOLOGY OF ALZHEIMER DISEASE Introduction
Neuropathological examination of the b.rain after au topsy of an Alzheimer disease (AD) patient will reveal a number of characteristic pathological changes comprising senile plaques, neurofibrillary tangles, congophilic angi opathy (CA) of the vessels, neuropil threads and neuronal cell loss. The amyloid (3 protein (A(3) is the major com ponent of both senile plaques and CA. Both lesions are found in the brains from patients with AD, Down syndrome or hereditary cerebral hemorrhage with amyloidosisDutch type (HCHWA-D).
Two major types of senile plaques have been identi fied: classic and diffuse senile plaques, which are both abundant in AD brains. It is suggested that diffuse senile plaques gradually transform into the fibril-containing classic senile plaques (1) .
CA is found in both cortical and leptomeningeal ves sels of AD and Down syndrome brains. In HCHWA-D patients, severe cerebrovascular Ap deposition leads to small infarcts and to often fatal hemorrhages in the brains of these patients. A mutation at position 22 of the Ap sequence, substituting a glutamine for a glutamic acid (2) , is directly related to the deposition of Ap in diffuse senile plaques and CA. Another type of A(3 deposition, dyshoric angiopathy (DA), is observed around cortical vessels and is characterized by the infiltration of fine radiating de posits of amyloid into the nearby neuropil, which sug gests a vascular origin. The incidcnce of this type of am yloid deposition is increased proportionally to the severity of CA (3) and is usually found in conjunction with amyloid deposition in pre-capillary arterioles.
Rather than presenting a complete overview of the pathological aspects of these lesions, in this review we will focus on data that support the hypothesis that in AD a different pathogenesis exists for either senile plaques or CA. 
Amyloid Protein

A/3 in Senile Plaques and in Congophilic Angiopathy:
A (3 is a fragment of a large protein, designated as the amyloid precursor protein (APP), encoded by a gene on chromosome 21 (see [1] for a review of the cell biology of APP). The A(3 peptide that accumulates in AD brains is heterogeneous at its C-terminus, which results in pep tides of 39 to 43 amino acids long. Several studies have been published with regard to the exact length of A(3 in CA and senile plaques using chromatographic and mass spectrometry techniques or by immunohistochemistry us ing antibodies that specifically recognize either A(3N40 or A(3M2/43-Using these C-terminal-specific anti-A3 antibod ies, it was described that diffuse senile plaques in brains from normal individuals and AD patients only contained A-(31-42/43• A p,.40 was absent from, or present only in a mi nority of, diffuse senile plaques (4) (5) (6) . Furthermore, in brains from young Down syndrome patients, HCHWA-D patients, and in the cerebellum of Down syndrome and AD patients, i.e. in conditions in which classic senile plaques are almost completely absent, the diffuse senile plaques were predominantly composed of A pM2/43 (6 , 7) . In contrast, classic senile plaques contained both A p^o and Ap1.42/43 and also shorter AP peptides, truncated at the N-terminus, and starting at residue 11 or 17 (5, 6 , 8 ).
The Ap content of CA differs from that of diffuse se nile plaques, but shows similarities to classic senile plaques. Immunohistochemical data indicated that CA in AD and HCHWA-D contained both A p M0 and A p i.42/43 (5, 6 , 9, 10), although absence of A pM2 from these lesions has been reported as well (4) . Therefore, A pM0 may be the predominant species deposited in CA (4, 5, 9-11). Similar to CA and classic senile plaques, AP in DA was reported to contain both A p,.40 and A p,.42/43 (5) . CA also contains the N-terminal truncated Ap peptides starting at residues 11 or 17 (8) . However, data irom Down syn drome patients of different ages indicated that, whereas A p,..42/43 deposition precedes A pM0 depcsition in senile plaques, both isoforms seem to be deposited simulta neously in CA (11) . The observation that CA is com posed of both AfJ^o and APM2/43 is confirmed by chem ical analysis of amyloid-containing vessels (12) .
A number of familial AD cases have been linked to mutations either in the APP gene or in the presenilin 751 752 VERBEEK ET AL (PS)-l or PS-2 genes. Similar to cases of sporadic AD, the initial and most abundant Ap species in these patients is A pM2/43 (6 , 9, 13, 14) . Mutations at APP717 or in the PS-1 gene result in an increased A(3 burden in the brain (6 , 9, 13, 15) , whereas in cases with mutations in the PS-2 gene or at APP670/671, the Ap deposition is compa rable to that in sporadic AD (9, 14) . Furthermore, in all of these cases of familial AD, the severity and frequency of CA and its Ap composition were comparable to spo radic AD (6 , 9, 13, 14) , indicating that neither mutation leads to a predisposition for CA. Apart form the abovementioned HCHWA-D mutation at APP693, which leads to severe CA formation, another mutation at APP692 may also lead to increased formation of CA (16) . Thus, it is remarkable that mutations within the A(3 region of APP predispose to CA, whereas mutations in APP flanking the Ap sequence do not lead to increased CA formation.
In conclusion, it is likely that in general A pM2/43 is the major component of diffuse senile plaques and that both APj.40 and A pM2/43 are deposited in classic senile plaques, CA, and DA (4, 6) . The differential composition of Ap in CA and senile plaques and, more importantly, the dif ferences in timing of deposition of Ap species in these lesions suggest that the Ap in CA on the one hand, and in senile plaques on the other, is produced by distinct and probably independent mechanisms. This conclusion is supported by observations of cases with familial AD due to mutations in the PS-1 gene or at APP7l7. Due to these mutations the production of Ap,.^ is increased relative to APj.40 (17) (18) (19) , and, accordingly, parenchymal A p^ de position is also increased in these patients. However, this is not reflected in changes in the composition of CA, since A 0mo remains the predominant isoform in CA of these patients (9, 13), supporting differential effects of these mutations on the pathogenesis of either lesion.
A ¡3 Fibrillogenesis: Ap may exist in a soluble form as well as in a p-pleated sheet conformation (2 0 ), basically through the p-sheet structure of the residues 14-21 and 29-39/42 (20) . Ap,_42 is less soluble and forms fibrils faster than shorter isoforms (21 ) , which indicates that the C-terminal sequence of Ap is critical in the determination of the solubility of the peptide. The process of amyloid formation in vivo may be seeded or nucleated by trace amounts of amyloid fibrils (21) . Progression of amyloid formation may involve the incorporation of potentially soluble Ap peptides that aggregate onto the initially formed seed. Since APM2 is relatively insoluble compared with APj.40, small seeds of A p^ fibrils may grow rapidly by incorporation of A pM0, the isoform that is predomi nantly produced by cultured cells (19) . Formation of the fibril seed is, then, the rate-limiting step of amyloidogenesis, an event that apparently does not occur in the dif fuse senile plaques of the cerebellar molecular layer be cause these plaques do not acquire A P^ immunoreactivity or transform into classic senile plaques. Although this " seeding" theory sounds attractive, it cannot explain the differences in physical state of Ap between CA and dif fuse senile plaques. Whereas in the former lesion Ap mostly assembles into fibrils, in the latter, Ap is in a non aggregated form, despite the fact that both lesions contain A pM2/43. Therefore, A p^^i s not the only factor that de termines the assembly state of Ap. Other molecules po tentially involved in the formation of amyloid are the amyloidogenic non-Ap component of amyloid (NAC) (22) or Ap peptides modified by advanced glycation (23) , but both these components are produced in CA as well as in senile plaques. Locally produced Ap-associated fac tors, produced either in the vasculature or in the brain parenchyma, may also affect Ap fibrillogenesis. The role of such factors will be discussed in paragraph 4.
Cells
Cellular Involvement in the Generation o f Senile Plaques and Congophilic Angiopathy:
In situ hybridiza tion studies demonstrated that mRNA encoding for APP695 and APP751/770 was predominantly found in cortical pyramidal neurons (24) in both normal and AD brains, but not in glial or endothelial cells. Immunohistochemical staining of brain sections for APP confirmed that neurons of normal and AD brains, but not microglial cells or as trocytes, expressed APP (25) . Furthermore, in classic se nile plaques, dystrophic neurites are APP positive (25, 26) . These data suggest that neurons are the primary pro ducers of APP in the brain parenchyma.
Clusters of activated microglial cells, indicative of an inflammatory response, are associated with classic senile plaques (27, 28) . Given the absence of microglial APP expression, it is possible that they have a secondary func tion, e.g. in processing Ap into fibrils (29) . Alternatively, their expression of Fc and complement receptors (30) , and of a marker indicative of an enhanced lysosomal ac tivity (31) , suggests that they function as phagocytes and remove Ap (32) . An increased astrocyte reactivity can also be observed around senile plaques, probably follow ing microglial activation (28) .
In summary, it is likely that neurons are the major candidates for the production of APP and Ap in senile plaques, whereas microglial cells and astrocytes may have an accessory function in senile plaque formation. Activated glial cells are presumably involved in gener ating an inflammatory response to Ap production that may contribute to the formation of amyloid-containing classic senile plaques and to neuronal pathology (see be low) (reviewed in [33] ). The observations that cerebellar diffuse senile plaques are not accompanied by activated microglial and astrocytic cells (31, 3 4 ) and that these plaques do not mature into classic senile plaques and lack neuronal pathology support this view.
The production of Ap in CA is likely mediated by different cell types. It has been suggested that Ap fibrils • 
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There are indications that, depending on the degree of deposition, CA may lead to vascular malfunctioning. In contrast to the relatively mild CA in the majority of AD brains, patients with sporadic and severe CA may occa sionally suffer from cerebral hemorrhages due to vessel rupture. In these advanced stages of CA, an increase or activation of monocyte/macrophage lineage cells is ob served that, in exceptional cases, may lead to granulo matous angiitis (45) .
Cellular Degeneration in Senile Plaques and in Congophilic Angiopathy: The presence of neuronal degener ation in AD brains is represented by the formation of intraneuronal NFTs and dystrophic neurites. Several stud ies have indicated that neuronal degeneration may be re lated to the presence of Ap, but this molecule may also exert protective effects on neuronal cells: soluble Ap, added in low doses to cultures of freshly isolated neurons, may enhance the rate of survival (46) . However, reports describing a toxic effect of A(3 on neuronal cells are more numerous. Injection of isolated human amyloid cores containing aggregated Ap or synthetic AfJ into rat brains induced neurodegeneration (47) , which indicates that the peptide has a direct toxic effect. When administered to cultured neurons, Ap peptides, especially when aggre gated, induced neurotoxicity, loss of presynaptic termi nals, and the development of dystrophic neurites (48, 49) . The neurotoxic effect of pre-aggregated or soluble A (3 could be blocked by the amyloid-binding dye Congo red (48) , which is probably based on the inhibition of fibril formation or binding to preformed fibrils. These in vitro data on Ap-mediated neuronal toxicity correlate well with the pathology in the AD brain. Diffuse senile plaques that are composed of nonfibrillar Ap lack any sign of neuronal degeneration, whereas in classic senile plaques, A (3 fibrils and neurodegenerative changes coin cide.
A(3 may also cause neurodegeneration via indirect pathways. Neuronal ceil death may be mediated by for mation of the complement membrane attack complex (C5b-9), which has been demonstrated in dystrophic neu rites and neuropil threads (50) . Furthermore, Ap may stimulate microglial cells to produce neurotoxic sub stances, such as cytokines, proteases, and free radicals (51) . Also, astrocytes may contribute to neuronal damage by producing growth inhibitory compounds that impair neurite outgrowth (52) .
An important feature of CA is the degeneration of cells of the vascular wall. Several ultrastructural or imrnunohistochemical studies have demonstrated that endothelial cells, pericytes and smooth muscle cells (43, 53, 54) un dergo degeneration in amyloid-laden vessels. Sharply in contrast with the effects of synthetic Ap peptijdes on neu rons are the effects on cultured vascular cells. Whereas degeneration of cultured neurons can be induced by dif ferent Ap peptides (Ap,.39, A pM0 or A pM2), especially when aggregated, only A pM2-but not A pM0-caused degeneration of cultured leptomeningeal smooth muscle cells and pericytes (38, 41) . Moreover, only soluble Ap was found to induce these effects, and pre-aggregation of the peptide completely abolished its effects (55) . A re markable inversed effect was observed when synthetic AP peptides carrying the HCHWA-D mutation were ap plied to these cells in vitro. A robust degenerating effect on cultured smooth muscle cells and pericytes was ob served with HCHWA-D A pM0, but not with HCHWA-D APi.42 (41, 56) . This effect could be inhibited by Congo red (41) ( Table 1) , which suggests that Ap assembly is a common mechanism in the destructive effects of Ap on both vascular cells and neurons. The effects of AP pep tides carrying the HCHWA-D mutation on cultured neu rons have not been studied.
In summary, these studies indicate that the mechanisms that lead to the degeneration of either neuronal or vas cular cells may be essentially different and depend on the chemical and physical state of Ap, which implies that the cellular pathology observed in senile plaques and CA may have an independent etiology. Moreover, inflam matory reactions mediated by microglial cells may sig nificantly contribute to the neuronal damage, whereas vascular degeneration in AD usually proceeds in the vir tual absence of an inflammatory response. The severe vascular pathology of HCHWA-D can at least in part be explained by the profound degenerating effects of HCHWA-D A pM0 on smooth muscle cells and pericytes, although inflammatory mechanisms may have an addi tional effect on these cells in HCHWA-D brains.
Ap-associated Proteins in Senile Plaques and in Congophilic Angiopathy
Apart from Ap itself, several Ap-associated proteins have been identified in senile plaques (see Table 2 ). Al though many more proteins have been identified than those mentioned here, this review only focuses on those components that have been studied in more than one re port or in different Ap-containing lesions. These factors include heparan sulfate proteoglycan (HSPG) (57), ApoE (58), and several inflammatory proteins, which include the complement factors C lq, C3, C4 (59), the comple ment inhibitors C4-binding protein (C4bp), clusterin (ApoJ) and vitronectin (50), the acute phase proteins a,-antichymotrypsin (a r ACT) (60, 61) and amyloid P com ponent (62) (63) (64) , and the cytokine-inducible adhesion molecule ICAM-1 (65) (Fig. 2) . The presence of all these components has been unequivocally demonstrated in cor tical diffuse and classic senile plaques. Also, in cortical brain sections from young Down syndrome and HCHWA-D patients, where usually no classic senile plaques are found, a,-ACT, complement factors and HSPG can be found (66, 67) . The acute phase protein a 2-macroglobulin is only found in classic senile plaques, whereas APP is expressed in dystrophic neurites in this plaque type (26, 61, 62) . Only a limited number of the above-mentioned factors are expressed in cerebellar diffuse senile plaques. In these lesions ApoE has been detected (62), but we did not ob serve ICAM-1 expression in these lesions (68) (Fig. 2) . HSPG, clusterin and a 2-macroglobulin were also absent (62, 69) . Reports about early complement factors, a,-ACT and amyloid P component are conflicting (62, 63, 70) , which probably indicates that their expression is low or depends on the pathological state of the tissue. Re markably, we observed that ICAM-1 is expressed in the rare classic senile plaques of the granular or Purkinje cell layers of the cerebellum (68) . Other groups also reported expression of HSPG and a 2-macroglobulin in these clas sic senile plaques (62, 69) .
An explanation for the absence of several A(3-associated factors from cerebellar diffuse senile plaques may be that they are produced during the transformation of diffuse se nile plaques into classic senile plaques and may affect this transformation process. The production of A(3-associated components may be determined by the ceil populations of specific brain regions, e.g. the cerebral cortex vs the cere bellum. Neuronal or glial cells may have a different vul nerability to Ap and a differential capacity to produce Afiassociated factors, and there may be diminished interactions between glial and neuronal cells in the cerebellum due to lower cell numbers compared with the cerebral cortex. Al though the Ap of diffuse senile plaques is in a relatively "soluble" form, it is not cleared from the brain parenchy ma, which indicates that it is retained in the neuropil via binding to other factors. Several of the Ap-associated fac tors, such as ApoE, a r ACT, Clq, clusterin, and HSPG, can bind to Ap (71) (72) (73) (74) (75) . The Ap-associated components a r ACT, ApoE (76), C lq (73) and HSPG (77) may accelerate Ap fibril formation, as was observed under various exper imental conditions. However, the Ap-associated protein •'•• '/ /y î -
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. V . exception of rare cases of vasculitis-evoked only in the latter lesion, which contributes significantly to a different pathogenesis of either lesion. The observations on DA clearly illustrate this different response to amyloid be cause inflammatory products are only generated when the vascular amyloid penetrates the brain parenchyma. Al though pericytes and smooth muscle cells are able to pro duce inflammatory reaction products such as ICAM-1 (40) and a r ACT (our unpublished observations), they do not deposit these factors in CA. The physical state of Ap in senile plaques may be affected by a number of inflam matory proteins. Other factors, such as basement mem brane components, may affect Ap fibrillogenesis in CA, whereas ApoE and HSPG may be involved in A3 fibril formation in both senile plaques and CA.
CONCLUDING REMARKS
In this review we summarized data from studies in which a variety of analytical approaches were used to demonstrate that the structure, composition and patho genesis of CA is different from that of senile plaques. The differences in Ap isoforms that constitute the lesions, the effects of mutations in the APP or PS genes, the ex pression of Ap-associated factors, the cell types involved in Ap production, and the mechanisms of AP-mediated cellular degeneration all indicate that the pathogenesis of CA is different from that of senile plaques (Fig. 4) . One of the central issues that leads us to speculate that CA and senile plaques have a different pathogenesis is that during the formation of classic senile plaques an inflam matory reaction is generated that may play a significant role in the formation of Ap fibrils, whereas this does not occur in CA. Since these fibrils are toxic to neurons, in** flammatory reactions contribute to neuronal degeneration by direct and indirect mechanisms. In contrast, the rela tive absence of such reactions in CA and the lack of toxicity of Ap fibrils for vascular cells point towards al ternative cytotoxic mechanisms in the vasculature. Here, our in vitro data and that of others fit in to suggest that it is the non-fibrillar form of Ap that directly causes vas cular degeneration, independent of inflammatory reac tions or Ap fibril formation.
The pathogenesis of CA has received little attention in the past, as CA was thought to be a pathological lesion of minor importance in the AD brain. However, the ar guments summarized in this review warrant a more de tailed investigation of its pathogenesis. The impact of CA in AD brains may extend beyond vascular pathology only. Endothelial cells and, to a lesser extent, pericytes, are involved in maintaining the blood-brain barrier (87) . Degeneration of these cells in vessels affected by CA may lead to an impaired functioning of the blood-brain barrier in AD patients, which contributes to a disrupted microcirculation and energy supply to the brain (88) , which, in turn, will have profound effects on brain me tabolism in general.
It will be very important to study suitable and physi ologically relevant cell culture models that include hu man cerebral glial and neuronal cells on the one hand and vascular cells on the other hand to study the specific processes that lead to senile plaque or CA formation, respectively, in order to gain more insight into the pathobiology of AD. Furthermore, transgenic mice specifically developed to study the pathogenesis of CA rather than senile plaques will provide more insight into the specific mechanisms of CA formation and into its impact on brain metabolism. Since the contribution of CA to the devel opment of dementia and its effect on the formation of senile plaques are barely understood, such future studies may unravel the significance of CA for AD.
